Total Financial Statements: Fourth Quarter and Full Year 2009 Consolidated Accounts, IFRS
Total Financial Statements: Fourth Quarter and Full Year 2009 Consolidated Accounts, IFRS
Year Year
(a) 2009 2008
(M€)
ASSETS
Non-current assets
Intangible assets, net 7,514 5,845 5,341
Property, plant and equipment, net 51,590 49,292 46,142
Equity affiliates : investments and loans 13,624 13,685 14,668
Other investments 1,162 1,187 1,165
Hedging instruments of non-current financial debt 1,025 983 892
Other non-current assets 3,081 3,179 3,044
Current assets
Inventories, net 13,867 12,002 9,621
Accounts receivable, net 15,719 14,198 15,287
Other current assets 8,198 8,141 9,642
Current financial assets 311 329 187
Cash and cash equivalents 11,662 13,775 12,321
Shareholders' equity
Common shares 5,871 5,869 5,930
Paid-in surplus and retained earnings 55,372 53,136 52,947
Currency translation adjustment (5,069) (5,744) (4,876)
Treasury shares (3,622) (3,641) (5,009)
Non-current liabilities
Deferred income taxes 8,948 8,894 7,973
Employee benefits 2,040 2,013 2,011
Provisions and other non-current liabilities 9,381 7,936 7,858
Current liabilities
Accounts payable 15,383 13,916 14,815
Other creditors and accrued liabilities 11,908 13,951 11,632
Current borrowings 6,994 6,012 7,722
Other current financial liabilities 123 169 158
th rd th
4 quarter 3 quarter 4 quarter
2009 2009 2008
(M€)
Intangible assets and property, plant and equipment additions (3,204) (2,849) (3,987)
Acquisitions of subsidiaries, net of cash acquired (4) - (368)
Investments in equity affiliates and other securities (52) (133) (136)
Increase in non-current loans (264) (274) (267)
Total expenditures (3,524) (3,256) (4,758)
Proceeds from disposal of intangible assets and property, plant and equipment 19 4 73
Proceeds from disposal of subsidiaries, net of cash sold - - -
Proceeds from disposal of non-current investments 802 698 659
Repayment of non-current loans 123 105 211
Total divestments 944 807 943
Cash flow used in investing activities (2,580) (2,449) (3,815)
Year Year
2009 2008
(M€)
Intangible assets and property, plant and equipment additions (11,849) (11,861)
Acquisitions of subsidiaries, net of cash acquired (160) (559)
Investments in equity affiliates and other securities (400) (416)
Increase in non-current loans (940) (804)
Total expenditures (13,349) (13,640)
Proceeds from disposal of intangible assets and property, plant and equipment 138 130
Proceeds from disposal of subsidiaries, net of cash sold - 88
Proceeds from disposal of non-current investments 2,525 1,233
Repayment of non-current loans 418 1,134
Total divestments 3,081 2,585
Cash flow used in investing activities (10,268) (11,055)
(unaudited)
As of January 1, 2008 2,395,532,097 5,989 48,797 (4,396) (151,421,232) (5,532) 44,858 842 45,700
Transactions with shareholders (23,724,023) (59) (6,182) - 8,339,137 523 (5,718) (213) (5,931)
As of December 31, 2008 2,371,808,074 5,930 52,947 (4,876) (143,082,095) (5,009) 48,992 958 49,950
Transactions with shareholders (23,385,190) (59) (6,268) - 27,674,905 1,387 (4,940) (213) (5,153)
As of December 31, 2009 2,348,422,884 5,871 55,372 (5,069) (115,407,190) (3,622) 52,552 987 53,539
(1) Treasury shares related to the stock option purchase plans and restricted stock grants
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (a)
TOTAL
(unaudited)
Year Year
(M€) 2009 2008
Non-Group sales
Intersegment sales
Excise taxes
Revenues from sales
Operating expenses (17) 313 25 - 321
Depreciation, depletion and amortization of tangible assets and mineral interests (4) (285) 6 - (283)
Operating income (b) (21) 28 31 - 38
(c)
Equity in income (loss) of affiliates and other items (90) (22) 23 46 (43)
Tax on net operating income 17 (23) (5) (2) (13)
Net operating income (b) (94) (17) 49 44 (18)
Net cost of net debt -
Minority interests (2)
Net income (16)
(a) Adjustments include special items, inventory valuation effect and equity share of adjustments and selected items related to Sanofi-Aventis.
Non-Group sales
Intersegment sales
Excise taxes
Revenues from sales - - - - -
Operating expenses - 148 60 - 208
Depreciation, depletion and amortization of tangible assets and mineral interests - - (3) - (3)
Operating income (b) - 148 57 - 205
(c)
Equity in income (loss) of affiliates and other items (31) (19) (8) (22) (80)
Tax on net operating income - (49) (16) (1) (66)
Net operating income (b) (31) 80 33 (23) 59
Net cost of net debt -
Minority interests (5)
Net income 54
(a) Adjustments include special items, inventory valuation effect and equity share of adjustments and selected items related to Sanofi-Aventis.
Non-Group sales
Intersegment sales
Excise taxes
Revenues from sales - - - - -
Operating expenses - (3,561) (1,009) - (4,570)
Depreciation, depletion and amortization of tangible assets and mineral interests (171) - (6) - (177)
Operating income (b) (171) (3,561) (1,015) - (4,747)
(c)
Equity in income (loss) of affiliates and other items (86) (243) (59) (139) (527)
Tax on net operating income 57 1,166 349 - 1,572
Net operating income (b) (200) (2,638) (725) (139) (3,702)
Net cost of net debt -
Minority interests 35
Net income (3,667)
(a) Adjustments include special items, inventory valuation effect and equity share of adjustments related to Sanofi-Aventis.
Year 2009
Upstream Downstream Chemicals Corporate Intercompany Total
(M€)
Non-Group sales
Intersegment sales
Excise taxes
Revenues from sales
Operating expenses (17) 1,558 344 - 1,885
Depreciation, depletion and amortization of tangible assets and mineral interests (4) (347) (40) - (391)
Operating income (b) (21) 1,211 304 - 1,494
(c)
Equity in income (loss) of affiliates and other items (160) 22 (123) (117) (378)
Tax on net operating income 17 (413) (50) (3) (449)
Net operating income (b) (164) 820 131 (120) 667
Net cost of net debt -
Minority interests (4)
Net income 663
(a) Adjustments include special items, inventory valuation effect and equity share of adjustments and selected items related to Sanofi-Aventis.
Year 2009
Upstream Downstream Chemicals Corporate Intercompany Total
(M€)
Year 2008
Upstream Downstream Chemicals Corporate Intercompany Total
(M€)
Non-Group sales
Intersegment sales
Excise taxes
Revenues from sales - - - - -
Operating expenses - (2,776) (925) - (3,701)
Depreciation, depletion and amortization of tangible assets and mineral interests (171) - (6) - (177)
Operating income (b) (171) (2,776) (931) - (3,878)
(c)
Equity in income (loss) of affiliates and other items (164) (195) (82) (345) (786)
Tax on net operating income 57 927 329 (2) 1,311
Net operating income (b) (278) (2,044) (684) (347) (3,353)
Net cost of net debt -
Minority interests 23
Net income (3,330)
(a) Adjustments include special items, inventory valuation effect and equity share of adjustments related to Sanofi-Aventis.
Year 2008
Upstream Downstream Chemicals Corporate Intercompany Total
(M€)
(unaudited)
(unaudited)